These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
497 related articles for article (PubMed ID: 35215376)
1. Pre-Administration of Berberine Exerts Chemopreventive Effects in AOM/DSS-Induced Colitis-Associated Carcinogenesis Mice via Modulating Inflammation and Intestinal Microbiota. Deng J; Zhao L; Yuan X; Li Y; Shi J; Zhang H; Zhao Y; Han L; Wang H; Yan Y; Zhao H; Wang H; Zou F Nutrients; 2022 Feb; 14(4):. PubMed ID: 35215376 [TBL] [Abstract][Full Text] [Related]
2. Berberine inhibits intestinal carcinogenesis by suppressing intestinal pro-inflammatory genes and oncogenic factors through modulating gut microbiota. Chen H; Ye C; Cai B; Zhang F; Wang X; Zhang J; Zhang Z; Guo Y; Yao Q BMC Cancer; 2022 May; 22(1):566. PubMed ID: 35596224 [TBL] [Abstract][Full Text] [Related]
3. Integration of microbiome, metabolomics and transcriptome for in-depth understanding of berberine attenuates AOM/DSS-induced colitis-associated colorectal cancer. Wang M; Ma Y; Yu G; Zeng B; Yang W; Huang C; Dong Y; Tang B; Wu Z Biomed Pharmacother; 2024 Oct; 179():117292. PubMed ID: 39151314 [TBL] [Abstract][Full Text] [Related]
4. Anchang Yuyang Decoction inhibits experimental colitis-related carcinogenesis by regulating PPAR signaling pathway and affecting metabolic homeostasis of host and microbiota. Wei X; Liang J; Liu J; Dai Y; Leng X; Cheng Y; Chi L J Ethnopharmacol; 2024 May; 326():117995. PubMed ID: 38428656 [TBL] [Abstract][Full Text] [Related]
5. Berberine regulates short-chain fatty acid metabolism and alleviates the colitis-associated colorectal tumorigenesis through remodeling intestinal flora. Yan S; Chang J; Hao X; Liu J; Tan X; Geng Z; Wang Z Phytomedicine; 2022 Jul; 102():154217. PubMed ID: 35660350 [TBL] [Abstract][Full Text] [Related]
6. A Holistic View of Berberine Inhibiting Intestinal Carcinogenesis in Conventional Mice Based on Microbiome-Metabolomics Analysis. Chen H; Zhang F; Zhang J; Zhang X; Guo Y; Yao Q Front Immunol; 2020; 11():588079. PubMed ID: 33072135 [TBL] [Abstract][Full Text] [Related]
7. Berberine ameliorates DSS-induced intestinal mucosal barrier dysfunction through microbiota-dependence and Wnt/β-catenin pathway. Dong Y; Fan H; Zhang Z; Jiang F; Li M; Zhou H; Guo W; Zhang Z; Kang Z; Gui Y; Shou Z; Li J; Zhu R; Fu Y; Sarapultsev A; Wang H; Luo S; Zhang G; Hu D Int J Biol Sci; 2022; 18(4):1381-1397. PubMed ID: 35280677 [TBL] [Abstract][Full Text] [Related]
8. Modulation of Gut Microbiota Combined with Upregulation of Intestinal Tight Junction Explains Anti-Inflammatory Effect of Corylin on Colitis-Associated Cancer in Mice. Chang ZY; Liu HM; Leu YL; Hsu CH; Lee TY Int J Mol Sci; 2022 Feb; 23(5):. PubMed ID: 35269806 [TBL] [Abstract][Full Text] [Related]
9. Ma F; Sun M; Song Y; Wang A; Jiang S; Qian F; Mu G; Tuo Y Nutrients; 2022 May; 14(9):. PubMed ID: 35565884 [TBL] [Abstract][Full Text] [Related]
10. Berberine Depresses Inflammation and Adjusts Smooth Muscle to Ameliorate Ulcerative Colitis of Cats by Regulating Gut Microbiota. Li X; Xu S; Zhang Y; Li K; Gao XJ; Guo MY Microbiol Spectr; 2022 Dec; 10(6):e0320722. PubMed ID: 36287004 [TBL] [Abstract][Full Text] [Related]
11. Berberrubine attenuates mucosal lesions and inflammation in dextran sodium sulfate-induced colitis in mice. Yu XT; Xu YF; Huang YF; Qu C; Xu LQ; Su ZR; Zeng HF; Zheng L; Yi TG; Li HL; Chen JP; Zhang XJ PLoS One; 2018; 13(3):e0194069. PubMed ID: 29538417 [TBL] [Abstract][Full Text] [Related]
12. AC1Q3QWB inhibits colorectal cancer progression by modulating the immune response and balancing the structure of the intestinal microbiota. Zhu W; Li J; Chen Y; Liu Z; Zhang Q; Kang C Int Immunopharmacol; 2023 Mar; 116():109768. PubMed ID: 36731153 [TBL] [Abstract][Full Text] [Related]
13. Berberine ameliorates chronic relapsing dextran sulfate sodium-induced colitis in C57BL/6 mice by suppressing Th17 responses. Li YH; Xiao HT; Hu DD; Fatima S; Lin CY; Mu HX; Lee NP; Bian ZX Pharmacol Res; 2016 Aug; 110():227-239. PubMed ID: 26969793 [TBL] [Abstract][Full Text] [Related]
14. Protective effect of Pai-Nong-San against AOM/DSS-induced CAC in mice through inhibiting the Wnt signaling pathway. Zhang MM; Yin DK; Rui XL; Shao FP; Li JC; Xu L; Yang Y Chin J Nat Med; 2021 Dec; 19(12):912-920. PubMed ID: 34961589 [TBL] [Abstract][Full Text] [Related]
15. Clostridium butyricum modulates gut microbiota and reduces colitis associated colon cancer in mice. Liu M; Xie W; Wan X; Deng T Int Immunopharmacol; 2020 Nov; 88():106862. PubMed ID: 32771947 [TBL] [Abstract][Full Text] [Related]
16. [Experimental study on effects of berberine combined with 6-shogaol on intestinal inflammation and flora in mice with ulcerative colitis]. Wei HL; Li JT; Chen ZG; Yan SG Zhongguo Zhong Yao Za Zhi; 2022 Aug; 47(16):4418-4427. PubMed ID: 36046871 [TBL] [Abstract][Full Text] [Related]
17. Lactobacillus coryniformis MXJ32 administration ameliorates azoxymethane/dextran sulfate sodium-induced colitis-associated colorectal cancer via reshaping intestinal microenvironment and alleviating inflammatory response. Wang T; Zhang L; Wang P; Liu Y; Wang G; Shan Y; Yi Y; Zhou Y; Liu B; Wang X; Lü X Eur J Nutr; 2022 Feb; 61(1):85-99. PubMed ID: 34185157 [TBL] [Abstract][Full Text] [Related]
18. Effect and Mechanism of Pharmaceutical Excipients on Berberine to Alleviate Ulcerative Colitis via Regulating Gut Microbiota. Wu C; Zheng T; Chen H; Zou P; Zhang M; Wang J; Li N; Zhang Y; Li Y; Dong Z Molecules; 2022 Sep; 27(18):. PubMed ID: 36144733 [TBL] [Abstract][Full Text] [Related]
19. Berberine inhibits dendritic cells differentiation in DSS-induced colitis by promoting Bacteroides fragilis. Zheng C; Wang Y; Xu Y; Zhou L; Hassan S; Xu G; Zou X; Zhang M Int Immunopharmacol; 2021 Dec; 101(Pt A):108329. PubMed ID: 34749293 [TBL] [Abstract][Full Text] [Related]
20. The Effects of Cellulose on AOM/DSS-Treated C57BL/6 Colorectal Cancer Mice by Changing Intestinal Flora Composition and Inflammatory Factors. Li Q; Chen C; Liu C; Sun W; Liu X; Ci Y; Song Y Nutr Cancer; 2021; 73(3):502-513. PubMed ID: 32351134 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]